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To obtain further information regarding the role of 
cytokines during mast cell differentiation, we have in-
vestigated changes of cytokine secretion in mast cells 
developing from the human peripheral blood mono-
cytic cell fraction during culture with fibroblast-
derived conditioned media. The influence of stem cell 
factor and an antibody to the respective receptor in our 
culture system was studied as well. 
Interleukin (IL)-1a, IL-1P, IL-6, and tumor necrosis 
factor (TNF)a were spontaneously secreted by cul-
tured cells at day 1 and decreased markedly by day 14. 
Similar changes occurred also during culture with 
stem cell factor and were partially abrogated by an 
anti-receptor antibody. IL-8 was secreted at a high level 
M ast cells play an important role in immediate hy-persensitivity responses, and their numbers are in-creased in a broad spectrum of pathologic condi-tions. Until now, little has been known about factors controlling mast cell proliferation and dif-
ferentiation [1-3], and better knowledge of these processes might 
provide insights into the involvement of these cells in tissue physi-
ology and pathology. 
Various cytokines (interleukin [ILJ-3, IL-4, IL-9, IL-I0 and more 
recently stem cell factor [SCF]) [4,5] have so far been shown to 
influence murine, and in the case of SCF, also human mast cell 
differentiation from bone marrow and umbilical cord blood pro-
genitor cells [6,7] . In the human system, SCF seems to be a decisive 
factor in mast cell differentiation. The receptor for SCF is encoded 
by the c-kit proto-oncogene [8,9]. Mouse strains with a genomic 
defect for c-kit or SCF have a profound deficiency of mast cells 
[10,11]. 
We have previously shown that in vitro, mast cells differentiate 
from the peripheral blood monocytic cell (PBMe) fraction in the 
presence of conditioned medium containing horse serum (HS) and 
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throughout the culture, whereas no spontaneous se-
cretion of IL-2, IL-3, IL-4, and IL-7 was measured at 
all. Upon stimulation with phorbol myristate acetate 
and A23187, cultured cells showed substantially more 
release ofIL-3 and TNF-a after 14 d of culture, com-
pared to peripheral blood monocytic cells. Preformed 
TNF-a was found in one of three monocytic cell prep-
arations from peripheral blood, but not in monocytic 
cell-derived mast cells. During mast cell differentia-
tion, cytokines from monocytic cells are therefore 
downregulated while the cells assume a pattern typi-
cally found in mast cells. Key words: mast cell differentia-
tion/SCF/TNF-a/tryptase. ] Invest Dermatol 103:504-
508,1994 
supernatants of a mouse fibroblast cell line (L-cells) (LCS), but not 
under serum-free conditions. Mast cell maturation was proven by 
the development of metachromasia with toluidine blue, by staining 
for chloroacetate esterase, by tryptase activity, by increasing hista-
mine contents, and, using immunohistochemistry, by demonstrat-
ing the expression of mast cell markers such as the a-chain of the 
high affinity immunoglobulin (Ig)E receptor and the c-kit protein 
[12-14].t 
In more recent studies, we could show that culture ofPBMC with 
HS, and with SCF added instead ofLCS, also results in an increase of 
cells positively staining for the a-chain of the FceRI (antibody 
29C6) [15] and the mast cell-specific tryptase (antibody AA1) [16]. 
Cultures with conditioned medium (HS/LCS) plus an SCF-recep-
tor antibody (YBs.B8) [17] led to a distinct decrease of 29C6- and 
AA1-reactive cells.=!: 
To explore the role of various cytokines known to influence mast 
cell development in the murine system [4-6], we investigated 
spontaneous and stimulated release of a number of cytokines from 
monocytic cells at the beginning and after 2-8 weeks of culture in 
the presence of HS/LCS. 
The pattern of cytokine secretion from these itl vitro differen-
tiated mast cells was compared to that of a human mast cell line, 
HMC-1.§ 
t Grabbe J, Welker P, Bauer E, Nordheim R, Czarnetzki BM: Mast cell 
characteristics induced by fibroblasts in different myeloid and immature 
mast cells (abstr) . ] Invest Dermatol 98:824, 1992. 
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Table I. Spontaneous Cytokine Release in Culture Supernatants ofPBMCs Differentiating into Mast Cells 
Day of Culture 
6 13 13 52 
Culture With 
Cytokine' HS/LCS HS/LCS HS/LCS SFM HS/LCS 
lL-la (pg/ml) 27.50 ± O.BO 19.60 ± 0.70 14.30 ± 0.50 1B.30 ± 0.600 0.00 
lL-1P (pg/ml) 41.00 ± 1.50 3.BO ± 0.10 3.60 ± 0.10 79.00 ± 2.300 0.00 
IL-6 (ng/ml) 6.90 ± 0.20 1.20 ± 0.05 1.00 ± 0.02 2.00 ± 0.100 0.10 ± 0.002 
lL-8 (Jig/ml) 0.21 ± 0.01 0.19 ± 0.01 0.20 ± 0.01 0.14 ± 0.006 0.19 ± 0.005 
TNF-a (pg/ml) 76.20 ± 2.BO 14.00 ± 0.50 5.00 ± 0.20 62.00 ± 0.300 4.00 ± 0.100 
• Data arc expressed as amount of mediators/10· viable cultured cells (mean ± range of duplicate; two samples of 200 ttl each were raken per point). 
Furthermore, SCF and an SCF-receptor antibody (YB5.B8) were 
studied in our cu lture system regarding their effects on cytokine 
release. 
The present data show that mast cells cultured from PBMCs 
reveal the cytokine pattern typically found in human mast cells.§ 
Furthermore, the findings provide first insights into a potential 
autocrine role of mediators secreted by the differentiating cells. 
MATERIALS AND METHODS 
Culture Media Supernatants were obtained from confluent cells of a 
murine fibroblast cell line (L-cells) after 5 d of culture in Dulbecco's mini-
mum essential medium (DMEM) (Gibco, Eggenstein, Germany) with 5% 
newborn calf serum (NCS) . HS and NCS were purchased from Seromed, 
Berlin, Germany. Serum-free medium (SFM) consisted of Is cove's modified 
Dulbecco's medium (Seromed, Berlin, Germany) supplemented with bo-
vine serum albumin (1.2 mg/ml), transferrin (33.4 ,ug/ml), and soybean 
lipids (2.4 ,ug/ml) (Boehringer, Mannheim, Germany). 
Cells PBMCs were prepared from peripheral blood of five healthy donors 
by differential centrifugation on Ficoll-Hypaque and adherence to polysty-
rene culture flasks. Nonadherent cells were removed from the flasks by 
washing with phosphate-buffered saline (PBS). The adherent cell fraction 
consisted ofBO-95% CD 14-positive cells before culture, as determined by 
fluorescence-activated cell sorter (FACS) analysis. Determination of mast 
cells was done by immunohistochemistry, using the tryptase-specific mono-
clonal antibody AAl, kindly provided by Dr. A.F. Walls. The human mast 
ceHline HMC-l was kindly provided by Dr. J.H. Butterfield, Minneapolis, 
MN[IB]. 
Cell Culture PBMCs were incubated in SFM, with 30% LCS or recom-
binant human SCF (5 or 50 ng/ml) (kindly provided by Dr. M. Brockhaus, 
Hoffman-La Roche Ltd., Basel, Switzerland) and with 30% HS for up to 52 
d, with changes of conditioning media every other day. In cultures with cells 
from two donors, an SCF-receptor antibody (YB5 .BB) (2,ug/ml) was added 
to the media at days 0 and 7. An antibody of the same isotype (anti-des min) 
(Dako, Denmark) (2,ug/ml) was used as control. Both antibodies had been 
purified by high-performance liquid chromatography (HPLC) and exten-
sively dialyzed. Viability at day 0 and at the end of itl vitro culture was 
determined by trypan blue exclusion and was> 90% at day 0 and 40 - 60% 
after 14 and 52 d of culture, after cell harvest. 
HMC-l were cultured in RPMI medium (GIBCO) with 10% FCS (Ser-
omed, Berlin, Germany) and 10- 5 M monothioglycerol (Sigma, Deisenho-
fen, Germany). 
Cell Stimulation The adherent cells were harvested by scraping from 
culture flasks (at days 0 and 14), and adherent and nonadherent cells of day 
14 cultures were pooled. Viable cells (1 X 106/ml) in RPMI were stimulated 
in 24-well polystyrene plates for cytokine release with a combination of 
phorbol myristate acetate (PMA) (25 ng/ml) and A231B7 (0.2 ,11M) (both 
from Sigma) for 24 h at 37'C. HMCI cells were stimulated the same way. 
Measurement ofCytokines Cytokines (ILs 1-4, ILs 6-B, tumor necrosis 
factor [TNF]-a) in cell supernatants or celllysates (prepared by three cycles 
of freeze-thaw ing) were quantified by enzyme-linked immunosorbent assay 
(ELISA) (Quantikine, Fa. Biermann, Bad Nauheim, Germany), and data 
were expressed as means of two values calculated for 106 viable cells. Data of 
duplicate measurements fluctuated within a very narrow margin «5%). 
Statistics Statistical significance was calculated with an unpaired two-
tailed t test. Spontaneous cytokine release and mast ce ll numbers in culture 
were evaluated by calculation of the correlation coefficient. 
RESULTS 
Release of Cytokines During Culture of PBMCs Prior to 
addition to cultures, the conditioning media themselves were ana-
lyzed for cytokine contents and w ere found to be negative for all 
cytokines studied here except for trace amounts of IL-8 in HS (1.8 
pg/ml) and in LCS (0.06 pg/ml) . These values are 100 times lower 
than those measured in cul ture supernatants. 
Based on tryptase staining, the percentage of mast cells at differ-
ent days of culture was day 0 = 0%, day 13 = 42 ± 22%, day 52 = 
51 ± 25% (n = 5). Contents of various cytokines in the superna-
tants ofPBMCs cultured for 24 h and for up to 52 d were measured 
in five different experiments. IL-2, IL-3, IL-4, and IL-7 were not 
detected in the PBMC culture supernatants at any timepoint, 
whereas measurable levels of IL-1a, IL-1f!, IL-6, and TNF-a were 
noted on day 1 (Table I, representative data from one donor). The 
levels of these four cytokines decreased reproducibly (Table II) up 
to day 52 of cu lture. High levels ofIL-8 were measured as well, but 
they remained constant throughout culture (Tables I and II). 
To evaluate the role of serum factors in the conditioning me-
dium, cells from the same donors were also cultured in SFM. After 
13 d of culture, only a minimal upregulation of mast cell markers 
could be detected immunohistochemically (only 2 ± 2% mast cells 
at day 13). Cytokine levels in the supernatants ofSFM cultures also 
generally declined after 2 weeks, compared to day 1, with the ex-
ception ofIL-If!. Compared to culture in HS/LCS on day 13, val-
ues for IL-1a, IL-lf!, IL-6 , and TNF-a were, however, higher 
(Table I). 
The correlation between the decrease of spontaneous IL-1a, IL-
1f!, IL-6, and TNF-a release and the number of tryptase-positive 
mast cells was significant (p < 0 .05) when data from all experi-
ments under different cu lture conditions were analyzed (n = 9) 
(Table ill). 
Stitnulated Cytokine Release Prior to culture, PBMCs re-
leased measurable quantities of IL-1a, IL-1f!, IL-6, IL-8, and 
TNF-a after stimulation with a combination of PMA/ A23187 for 
24 h (Table IV). Secretion ofIL-la, IL-If!, and IL-6 was markedly 
Table II. Changes in Cytokine Contents of Culture 
Supernatants· 
CytOkiJ1C 
IL-la 
IL-1{J 
IL-6 
IL-B 
TNF-a 
Percent Reductionb 
40.B ± 7.4' 
B9.2 ± 11.2' 
81.7±9.1' 
3.B ± 0.5J 
91.6 ± 10.3' 
• Experiments with cel ls from five different normal donors, cultured with HS and 
LCS. 
• Reduction of cytokine levels (means ± SO) at day 13 of culture, compared to levels 
at day I, set at 100%. 
'p < O.OOL 
J Not significant. 
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Table m . Correlation of Changes in Spontaneous 
Cytokine Release with the Number 
of Tryptase-Positive Cells 
Cytokine Correlation Significance (p) 
IL-lO' 
IL-1P 
IL-6 
TNF-O' 
0.84 
0.80 
0.72 
0.82 
< 0.001 
< 0.01 
< 0.05 
< 0.01 
lower in cultured cells (p < 0.05). In contrast, the capability of the 
cells to release IL-3 and TNF-O' increased by day 13 (p < 0.05). The 
increase of IL-8 release was not significant. 
Stimulation of the human mast cell line HMC-l in the same 
fashion showed no or lower secretion of IL-IO', IL-1P, and IL-6, 
compared to PBMCs (Table IV) . The amount of IL-8 secreted by 
the three cell types was comparable, and production of IL-3 and 
TNF-a was higher in cultured mast cells compared to PBMCs. 
In PBMCs held in SFM, stimulated release ofIL-la, IL-1P, and 
IL-6 decreased as well during culture, whereas secretion ofTNF-a 
increased slightly and that of IL-3 and IL-8 remained unaffected . 
Comparing cytokine secretion by PMBCs cultured in HS/LCS 
versus SFM, significant differences were noted only for IL-3 and 
TNF-a (Table IV). 
Influence of SCF on Cytokine Release To examine whether 
SCF had the same effect as LCS on cytokine secretion from PMBCs, 
spontaneous cytokine release was measured from cells kept in HS/ 
LCS, HS + SCF (5 ng/ml), and HS + SCF (50 ng/ml) (Fig 1). 
The percentages of mast cells in these experiments were day 0, 0%; 
day 13 (30% LCS), 22 ± 12%; day 13 (5 ng SCF), 39 ± 15%; day 
13 (50 ng SCF), 46 ± 18% (n = 3). 
Addition of SCF (5 or 50 ng/ml) caused a marked decrease of 
spontaneous IL-10" (Fig 1a), IL-1P (Fig 1b), and TNFa (Fig 1e) 
release on days 6 and 13, compared to cells after 1 d of culture 
(p < 0.022). For IL-1p (Fig lb), more cytokine re lease was noted 
during the first day of culture in SCF, compared to LCS (p < 0.04). 
Levels ofIL-la and TNF-a at days 6 and 13 of culture in SCF were 
lower compared to LCS (p < 0.02), whereas the effect of LCS and 
SCF on spontaneous secretion ofIL-6 and IL-8 was equal through-
out culture (data not shown) . A clear dose dependency between the 
effects of 5 and 50 ng SCF/ml could not be established. 
To provide further evidence that the effects observed regarding 
cytokine secretion of PBMCs differentiating towards mast cells 
were indeed due to SCF, an antibody against the SCF receptor 
(YB5.B8) was added to the conditioning media containing HS/ 
LCS at days 0 and 7 of culture . The percentages of mast cells in the 
two experiments done were day 0, 0%; day 13 (without antibody), 
30%; day 13 (antibody YB5 .B8), 10% (n = 2) . 
The SCF-receptor antibody partially prevented the decrease of 
IL-la, IL-1P, and TNF-a as normally observed during culture, 
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whereas no effect was noted on IL-6 and IL-8 release . An irrelevant 
antibody of the same isotype had no effect (data not shown). 
Studies on Preformed TNF-O' In the literature, TNF-a has 
been described as being stored preformed within mast cells [1 9,20]. 
We therefore tried to detect preformed TNF-a in freshly prepared 
PBMCs and in mast cells that had developed after 2 weeks of in vitro 
culture with HS/LCS from PBMCs. Ceillysates and supernatants 
were analyzed before and after 1 h of stimulation with a combina-
tion of PMA/ A23187. 
After 2 weeks of culture, unstimulated and stimulated cells from 
three different normal donors contained no preformed TNF-a in 
celllysates and cell supernatants. Only in freshly prepared PBMCs 
from one of the three donors could TNF-a be detected (107 pg/106 
cells in the lysate of unstimulated cells). There was 50 pg/ml re-
leased into the supernatants by the cells of this donor after 1 h of 
stimulation with PMA/ A23187. 
DISCUSSION 
In this study, we have investigated the cytokine secretion pattern of 
monocytic cells differentiating into immature mast cells during cul-
ture with HS/LCS. We demonstrate that during the course of cul-
ture, the cells change their pattern of spontaneous and stimulated 
cytokine release to that of immature mast cells, as exemplified by 
the immature mast cells of the HMC-l line. 
In previous experiments, we have reported that under the influ-
ence of fibroblast-derived factors, cells from the monocytic fraction 
of human peripheral blood and monocytic and pro myelocytic cell 
lines develop histochemical, immunohistochemical, and functional 
characteristics of mast cells [12,13] . The percentage of the original 
adherent cell population developing mast cell characteristics varies, 
depending on the investigated mast cell markers and the individual 
donors. Maturation of an immature mast cell line can be induced as 
well [13].t 
One of the decisive factors in mast cell differentiation and matu-
ration may be SCF, also named mast cell growth factor [8].:!: SCF 
was originally identified as the gene product of the murine steel 
locus on chromosome 10 and as a ligand for the c-kit protein [9,10]. 
It has been shown to be a potent stimulator of mast cell growth and 
granule protein synthesis in murine bone marrow cells [21] . Valent 
et af have reported similar effects after 4 weeks of human bone 
marrow and peripheral blood mononuclear cell culture with SCF 
[8] and SCF has been shown to generate and maintain immature, 
mucosa-type mast cells in 14-week culture of human cord blood 
cells [22]. We have studied this factor for its effect on human pe-
ripheral blood monocytic cells in our culture system and have 
shown previously that all tested mast cell characteristics were mark-
edly upregulated, while an antibody to the SCF receptor had a 
partially downregulating effect.:!: Our data suggest that SCF is a 
definite but not a unique factor for human mast cell differentiation. 
In the murine system, the participation of other cytokines in the 
differentiation process has been studied extensively, with IL-3, IL-
Table IV. Stimulated Cytokine Release from Different Cell Types (Means ± SO) 
PBMCs, 13-d Culture 
PBMCs (fresh) In HS/LCS' 
Cytokine (n=3) (n = 3) 
IL-1O' (pg/ml) 27.40 ± 5.20 10.40 ± 4.90d 
IL-IP (pg/ml) 344.00 ± 185 76.20 ± 41.0d 
IL-3 (ng/ml) 0.00 ± 0.00 0.57 ± 0.20' 
IL·6 (ng/mJ) 3.80 ± 1.50 0.37 ± 0.10d 
IL·8 {jLg/ml) 0.14 ± 0.05 0.19 ± 0.02' 
TNF-Q' (ng/ml) 0.25 ± 0.10 1.36 ± 0.30' 
• Statistical significance Was calculated comparing fresh with cultured PBMCs. 
I Statistical significance was calculated comparing cultured PBMC in HS/LCS versus SFM. 
'p < O.O !. 
'P < 0.05. 
, Not significant. 
In SFMb 
(n = 3) 
14.2 ± 4.7' 
81.3 ± 12.2' 
0.00 ± 0.00' 
0.80 ± 0.30' 
0.13 ± 0.04' 
0.60 ± 0.15' 
HMCl 
(n = 1) 
0.00 
22.00 
0.50 
2.80 
0.15 
2.60 
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4, IL-6, IL-9, IL-I0, nerve growth factor (NGF), and granulocyte-
macrophage colony stimulating factor (GM-CSF) all being reported 
to influence the maturation or proliferation of mast cells [4 -6]. In 
the human system, only a few studies reporting effects of these 
factors have been published. Sillaber et at showed that IL-4 downre-
gulates the expression of the c-kit gene product in human mast and 
myeloid progenitors cells [23] . The effect of IL-3 is controversial; 
Kirshenbaum et at [7) described the production ofbasophils and mast 
cells from CD34-positive cells with IL-3, whereas Valent et at found 
no effect of IL-3, IL-4, IL-9, and GM-CSF on mast cell differentia-
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Figure 1. Time course of spontaneous cytokine release from PBMC 
and PBMC-derived mast cells. Cytokines (mean ± so from data) were 
determined in culture supernatants on days 1,6, and 13. Cultures were done 
in HS/ LCS (a) , HS/SCF (5 ng/ ml) (b) or HS/ SCF (50 ng/ml) (c) . a) 
IL-1a, b) IL-lfJ, c) TNFa. 
tion from bone marrow and peripheral mononuclear cells [8). IL-3, 
but no other cytokine, stimulated, on the other hand, basophil dif-
ferentiation in this system [24). 
In the present studies, IL-2, IL-3 , IL-4, and IL-7 were not de-
tected in the supernatants of the cultured and differentiated cells. It 
is therefore unlikely that these factors play an important role in the 
differentiation of monocytic cells towards mast cells in our culture 
system. We could show, however, that the concentrations ofIL-la, 
IL- lP, IL-6, and TNF-a decreased in culture with HS/LCS, in 
parallel with an increase of mast cell characteristics. It remains to be 
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determined whether the addition of these cytokines to cultures or 
the blocking of these effects influences the differentiation process. 
In preliminary work with IL-6, this seems indeed to be the case.~ 
On the other hand, the concentration of IL-8 remained almost 
constantly at a high level throughout the culture so that a modulat-
ing effect on the mast cell differentiation process by this cytokine 
remains possible but seems less likely. In serum-free cultures, de-
creased concentrations of IL-1a and IL-6 were observed after day 
13, compared to cultures on day 1. T N F-a levels were higher than 
in HS/LCS cultures, and IL-1/J levels were even above those on day 
1 (Table I). Because scarcely any mast cell development was ob-
served in SFM, the altered cytokine levels may be a reflection of 
non-mast cells releasing these factors. Because SCF is present in the 
HS/LCS cultures, and as it is known to stimulate mast cell secretion 
[25], the altered cytokine levels in the SFM culture supernatants 
may reflect the lack of SCF action. 
In addition to the spontaneous cytokine secretion, changes were 
also noted in the pattern of stimulated cytokine release from cul-
tured, differentiating mast cells, compared to the initial cell popula-
tion in culture. The monocyte-derived mast cells resembled the 
human immature mast cell line HMC-1, with a lower release of 
IL-1a, IL-1/J, and IL-6 and an increase ofIL-3 and TNF-a (Table 
IV) compared to the seeded cells. In particular, the secretion ofIL-3 
and TNF-a from the cultured cells is striking because the mono-
cytic cells released no IL-3 at all and only little TNF-a, whereas 
these cytokines were secreted in substantial amounts by the HMC-1 
cells. This fits with data from the literature where human mast cells 
have been shown to be potent sources of these cytokines [20]. § 
In the present studies, we show that SCF, in parallel with differ-
entiation of monocytic cells towards mast celis, also induces a switch 
in cytokine release towards a pattern found in mast cells. The effects 
of HS/LCS were partially abrogated by culture with the SCF-re-
ceptor antibody YB5.B8 in two experiments, in parallel with the 
inhibition of mast cell development by this antibody.:!: These results 
emphasize that SCF plays an important role in mast cell differentia-
tion and that the changes in cytokine release pattern towards that of 
mast cells parallel this process. 
The presence of preformed TNF-a is described by Gordon et al 
[20] and Walsh et al [21] as typical for mast cells, whereas Benyon et 
al [26] were unable to detect TNF-a in unstimulated skin mast cells. 
In our experiments, we also failed to find preformed TNF-a in the 
in vitro differentiated mast cells. One reason could be the immaturity 
of these cells or lack of stimulatory factors operative in vivo. The 
detection of TNF-a in lysates of freshly prepared, unstimulated 
monocytes from one donor may be due to unspecific activation il'l 
vivo or during the isolation procedures. 
In conclusion, this study supports the concept that cells in the 
monocytic fraction of peripheral blood can differentiate towards 
mast cells under the influence of fibroblast-derived factors such as 
SCF, also on the basis of the cytokine pattern produced by these 
cells. Moreover, the present findings of changing cytokine patterns 
during itl vitro mast cell development suggest that the cultured cells 
themselves may regulate their differentiation. This potentially 
complex interaction will have to be elucidated further for each 
factor involved. 
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